Legionella pneumophila - Legionnaire Disease

Legionella pneumophila - Legionnaire Disease

 

Legionellosis refers to two clinical syndromes caused by bacteria of the genus Legionella – Legionnaire disease and Pontiac fever.

Epidemiology

  • Incidence – >10,000 annual cases of Legionnaire disease in U.S.
    • May be responsible for 3-8% of all community-acquired pneumonia (CAP)
  • Gender – M>F
  • Transmission
    • Most cases are sporadic
    • More common in summer months – outbreaks of pneumonia have occurred after inhalation of contaminated water droplets from water sources such as evaporative coolers, hot tubs, heating systems and respiratory therapy equipment
    • Person-to-person transmission has not been shown
    • Nosocomial cases are not uncommon, with sources of infection often being hospital showers, drinking fountains and respiratory-therapy equipment

Organism

  • Legionella is a gram-negative bacterium that parasitizes freshwater amoeba in the environment and pulmonary macrophages in humans
  • 42 species comprise 64 serogroups of Legionellae
  • L. pneumophila is the major pathogen and the most commonly encountered member of the group

Risk Factors

  • Compromised immune system (immunosuppressive therapy or T-cell dysfunction)
  • Underlying chronic disease (e.g., chronic obstructive pulmonary disease)
  • Recent surgery
  • Older age
  • Tobacco abuse

Clinical Presentation

  • Pontiac fever
    • A self-limiting, febrile illness with a non pneumonic, influenza-like illness
      • Usually affects healthy individuals
  • Legionnaire disease
    • Generally includes gastrointestinal symptoms - primarily loose stools, diarrhea and/or abdominal pain
    • Can be associated with a variety of other systemic problems, including kidney, liver and central nervous system dysfunction
    • The case-fatality rate for patients with legionellosis is 5-30%, with the elderly and immunocompromised patients at greater risk for death

Diagnosis

  • Laboratory testing
    • Rapid testing is important for early initiation of treatment
      • PCR testing of respiratory secretions
      • DFA or urine antigen testing 
        • Urine antigen testing is less sensitive
      • Serological testing may be used for retrospective diagnosis

Differential Diagnosis

  • Other atypical pneumonia (e.g. mycoplasma)

Treatment

  • Supportive
  • Antibiotic therapy

See Also